BrandShield Systems+ (BRSD, House Stock at 7p) - Strong FY22A results, ARR +61%

Hybridan Small Cap Feast - 03 Jul 23

3rd July 2023 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectiv

BrandShield Systems+ (BRSD, House Stock at 8p) - FY22A Results confirm strong ARR growth

Brandshield+ (BRSD, House Stock, 7p) - Annual Pharma Fraud Report

Brandshield+ (BRSD, House Stock, 7p) - Helping countries in SE Asia overcome digital fraud

Growth Companies - Share & share alike Sell in May?

BrandShield Systems+ (BRSD, House Stock, 5p) - Frost & Sullivan innovation award

SHORE CAPITAL - BrandShield Systems+ (BRSD, House Stock at 6p)

Hybridan Small Cap Feast - 28 Feb 23

28 February 2023 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objec

SHORE CAPITAL - BrandShield Systems+ (BRSD, House Stock, 5p) - FY22 update confirms strong performance

SHORE CAPITAL - BrandShield Systems+ (BRSD, House Stock, 6p)

SHORE CAPITAL - BRANDSHIELD SYSTEMS+ (BRSD, House Stock, 6p) – Global Surge in World Cup Cyber Fraud

SHORE CAPITAL - BrandShield Systems+ (BRSD) House Stock, 6p

Hybridan Small Cap Feast 03/11/22

Joiners: No joiners today. Leavers: No leavers today. What’s cooking in the IPO kitchen?** Life Sciences REIT plc (LABS.L), the AIM listed real estate investment trust focused on UK life science properties, announces that, in accordance with the intention expressed at the time of the Company's initial public offering on AIM, the board has determined to apply for the Company's existing ordinary shares to be admitted to listing on Premium Segment of the Main Market. The Company's admission to trad

SHORE CAPITAL - BrandShield Systems+ (BRSD) House Stock, 7p

Concurrent Technologies - FY23 trading update – revenue growth accelerating

Concurrent Technologies has released a FY23 trading update stating revenues in the current year are expected to be ahead of market expectations. Strong order intake has continued throughout the year and the significant investment in product development undertaken to target design-in wins has brought new customers (especially large Defence sector prime contractors), larger average single order sizes, and an increasing diversification of end markets. So far this year, Concurrent Technologies has w

Journeo - The Merry Journey Continues

Journeo has released a positive trading update following strong business activity in October and November. The company references strong trading in its core Fleet and Passenger Systems divisions, as well as the newly acquired Infotec and MultiQ divisions. We expect that the investment made in the Infotec factory to facilitate higher production speed has contributed to clearing the prior backlog and the ability to win new orders. We believe the positive trading momentum will continue into FY24E a

Altitude Group (ALT LN) - Continued rapid growth

Altitude’s interim results show continued strong trading and operational progress, with a positive outlook for the remainder of the year. FY24 revenue and adjusted EBITDA is expected to be in line with market expectations. The Group’s pipeline for university campus stores (Gear Shops) remains healthy and growing, with further contract announcements expected between March and June next year. Our average valuation estimate is now 57.8p per share (previously 57.6p), but material Gear Shop contract

Celebrus Technologies - Encouraging interims, and name change

Celebrus (formerly D4t4) 1H24 interims to September are in line with the October trading update and unchanged forecasts. The typical 1H/2H revenue split eased a touch to 40/60 from 38/62, taking 1H EBITDA to breakeven (after £-1.2m in 1H23) and en route to £5.7m for the full year (FY23: £3.7m, including £4.9m in 2H23). The delivery of the larger of the two lower margin orders, together worth c£6m and postponed from 2H23, has boosted 1H24, with cash to follow in 2H24. Net cash (no debt) of £14.7m

Crimson Tide - FY23 update: FY23E adj EBITDA +136%, FY24E reiterated

Crimson Tide has reported an encouraging FY23 trading update highlighting operating efficiencies in FY23, and a strong pipeline of new business with increasing visibility to support profitable recurring revenue growth. As a result of more efficient operations, the company delivered reduced spend in FY23, reinvesting part of the savings in growth marketing activities, including partner acquisition in the US and UK. We upgrade our FY23E adj EBITDA to £0.4m (was £0.2m) to include the savings, upgra

Morning Note – 28 November 2023

Morning Note – 29 November 2023

New balance

Morning Note – 27 November 2023

GENinCode - Transition to De Novo

Following discussions with the FDA, GENinCode has agreed to transition the FDA approval pathway for CARDIO inCode-Score (CIC-Score) to a De Novo submission from the previous 510(k) application. This transition will create a new regulatory class for polygenic risk score medical device tests and, assuming approval, could see CIC-Score established as the ‘predicate’ device against which future polygenic risk score tests are assessed, potentially creating a barrier to future competition given the cl

Synectics+ (SNX, House Stock at 103p) - UK contract win

The Joy of Techs - Cavendish Technology quarterly sector note

£23.3bn in enterprise value has been returned to AIM technology shareholders over the past six years in the form of 51 public to private takeouts, including 10 in 2023 alone with the takeovers of Smoove* and Tribal announced in early October. With UK valuations appearing cheap and looking more attractive to potential acquirers, we take a moment to reflect on the trends of corporate and private equity bidders targeting AIM-listed technology companies going back to 2017, through the uncertainties

Tracsis - Delivering growth now and investing in the future

Tracsis’s FY23 results demonstrate that it is reaping the benefits of organic and acquired growth as the March 2022 acquisition of Railcomm adds US growth to existing UK and Ireland strength and growth. 19% group revenue growth (10% organic) was delivered from 26.5% growth in Rail Technology & Services (RT&S), including 8% organic; and 14% growth in Data, Analytics, Consulting & Surveys (DACE), all organic. £82m revenue (vs £81.5mE) yielded EBITDA of £16m as expected, with £15.3m cash, no debt,

Free shares in a new company

At last week’s investor briefing, GHT lifted the lid on Floe – a new product which materially extends Gresham’s value proposition beyond Clareti (regulatory and operational FS software) to front-end banking software as well, specifically corporate banking account management – a large (but poorly served) market. This attitude is seemingly shared by ANZ - which has been key to Floe’s development and will be first to commercialise the software. And - subject to a successful rollout – its deal

IQGeo Group - H1 organic growth of +83%, 4-5% revenue & EBITDA upgrades

In today’s H1 results, IQGeo has announced H1 revenue growth of +124% yoy to £20.5m, adjusted EBITDA of £2.7m, and EFCF of +£0.3m. Excellent execution of the land and expand strategy scaled exit ARR +64% yoy to £16.9m, net recurring revenue retention increased to 114% from 108% in FY22, and recurring revenue grew +61% yoy to £7.2m. The +122% yoy growth in services revenue to £8.8m reflects vigorous demand from customers to implement and leverage the differentiated solutions, and as customers ext